Concepedia

Leonard Favreau

LF

Statistics

Publications

46

Citations

3.9K

H-Index

30

Active since

1963

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Canada Inc. (Canada)

LabCorp (United States)

Harvard University

Leonard Favreau is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryNatural SciencesDrug DiscoveryMedicinal ChemistryMetabolismDrug DevelopmentPharmacotherapyChemical Biology

Publications per year

1963–2018

46

Publications

46

A New Simple Semimicro Method for Colorimetric Determination of Urea

Jean-Franҫois Coulombe, Leonard Favreau · Clinical Chemistry · 1963 · 533 citations

Urology, Biochemistry, Medicine +14

Transcriptional regulation of the rat NAD(P)H:quinone reductase gene

Leonard Favreau, C.B. Pickett · Journal of Biological Chemistry · 1991 · 500 citations · Full text

Reductive Stress, Transcriptional Regulation, Aldehyde Dehydrogenase +15

Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.

John J. Castellot, Leonard Favreau, Morris J. Karnovsky et al. · Journal of Biological Chemistry · 1982 · 310 citations · Full text

Endothelial Cell-derived Heparin, Endothelial Cells, Much Inhibitory Activity +16

Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.

Deborah Slipetz, Gary P. O’Neill, Leonard Favreau et al. · Molecular Pharmacology · 1995 · 194 citations

Purification and properties of human platelet heparitinase.

G.M. Oosta, Leonard Favreau, David Beeler et al. · Journal of Biological Chemistry · 1982 · 156 citations · Full text

1–5 of 46